The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature

The efficacy and safety of the combination of endocrine therapy (ET) and CDK4/6 inhibitors for patients with hormone receptor (HR)-positive HER2-negative metastatic breast cancer (BC) presenting with visceral crisis or life-threatening conditions represent a challenge for daily clinical practice. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Garufi, Giovanna, Carbognin, Luisa, Orlandi, Armando, Palazzo, Antonella, Tortora, Giampaolo, Bria, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529000/
https://www.ncbi.nlm.nih.gov/pubmed/34692469
http://dx.doi.org/10.3389/fonc.2021.651723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529000/
https://www.ncbi.nlm.nih.gov/pubmed/34692469
http://dx.doi.org/10.3389/fonc.2021.651723

Ejemplares similares